Drug loaded implantable devices to treat cardiovascular disease
M Adhami, NK Martin, C Maguire… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction It is widely acknowledged that cardiovascular diseases (CVDs) continue to be
the leading cause of death globally. Furthermore, CVDs are the leading cause of diminished …
the leading cause of death globally. Furthermore, CVDs are the leading cause of diminished …
Polymers, drug release, and drug‐eluting stents
S Commandeur, HMM van Beusekom… - Journal of …, 2006 - Wiley Online Library
Implantable biomaterials mainly serve as physical support devices, carriers for bioactive
molecules and guidance for tissue growth. For any application within or outside the …
molecules and guidance for tissue growth. For any application within or outside the …
New frontiers in cardiology: drug-eluting stents: Part I
JE Sousa, PW Serruys, MA Costa - Circulation, 2003 - Am Heart Assoc
various coatings at different time intervals. The achievement of a hospitable relationship
between stent, coating matrix, drug, and vessel wall is extremely challenging. In principle …
between stent, coating matrix, drug, and vessel wall is extremely challenging. In principle …
Drug-eluting stents: A multidisciplinary success story
HM Burt, WL Hunter - Advanced drug delivery reviews, 2006 - Elsevier
Coronary stenting is the most common form of interventional treatment for symptomatic
coronary artery disease. In-stent restenosis following bare metal stent (BMS) placement is …
coronary artery disease. In-stent restenosis following bare metal stent (BMS) placement is …
Coating techniques and release kinetics of drug-eluting stents
M Livingston, A Tan - Journal of medical devices, 2016 - asmedigitalcollection.asme.org
Implantation of drug-eluting stents (DESs) via percutaneous coronary intervention is the
most popular treatment option to restore blood flow to occluded vasculature. The many …
most popular treatment option to restore blood flow to occluded vasculature. The many …
[HTML][HTML] Drug-Eluting Stents: Technical and Clinical Progress
M Koźlik, J Harpula, PJ Chuchra, M Nowak… - Biomimetics, 2023 - mdpi.com
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …
[HTML][HTML] Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Abstract Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step
in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its …
in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its …
The future of drug-eluting stents
N Kukreja, Y Onuma, J Daemen, PW Serruys - Pharmacological Research, 2008 - Elsevier
This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their
arrival in 2002, DES have transformed the practice of interventional cardiology by drastically …
arrival in 2002, DES have transformed the practice of interventional cardiology by drastically …
How safe and how good are drug-eluting stents?
AMN Kabir, A Selvarajah, AM Seifalian - Future cardiology, 2011 - Future Medicine
Percutaneous transluminal coronary angioplasty revolutionized therapy for coronary artery
disease. This early promise of a viable alternative to surgical treatment of coronary artery …
disease. This early promise of a viable alternative to surgical treatment of coronary artery …
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group
RS Schwartz, ER Edelman, A Carter, NA Chronos… - Circulation, 2004 - Am Heart Assoc
Drug-eluting stents implanted in the coronary arteries sub-stantially improve long-term
outcomes for restenosis. The utility of the stents in peripheral atherosclerosis is under …
outcomes for restenosis. The utility of the stents in peripheral atherosclerosis is under …